9 research outputs found

    The role of relaxin in the regulation of human liver and kidney fibrosis

    No full text
    Liver fibrosis has a range of aetiologies and is a global cause of mortality. Acritical effect of liver fibrosis which also increases mortality is portalhypertension. The hepatic stellate cell is accepted as a major progenitor of livermyofibroblasts, which have been shown to be a major source of collagen andextracellular matrix proteins that disrupt liver architecture and function. Relaxinis a hormone involved in remodelling of extracellular matrix in the uterus andcervix and is known to increase renal blood flow in pregnancy. It has beenimplicated in the regulation of fibrosis in animal models and to modify the cellbiology of hepatic stellate cells in vitro. I have demonstrated the profile ofexpression of relaxin receptors in primary human stellate cells (HSC), showingthem to express RXFP-1, 3 and 4. Using a cAMP assay I confirm these receptorsto be functional, with RXFP-1 positively and RXFP-3 and 4 negatively couplingto cAMP. The expression of RXFP-1 is coupled with the level of activation,demonstrating a possible role for H2-relaxin in the regulation of HSC. I haveestablished a dynamic regulation of fibrotic mediators and HSC activationmarkers, including a reduction in ?-SMA, TIMP-1 and TGF-? with increases inMMP-1 and MMP-2, consistent with H2-relaxin having potentially therapeuticantifibrotic effects by increasing the fibrolytic phenotype. In addition throughthe use of gel contraction assays I demonstrate that H2-relaxin reduces serum orendothelin-1 induced HSC contraction. Through the use of siRNA I haveconfirmed that H2-relaxin mediates its regulation of fibrotic mediators and HSCactivation markers as well as the inhibition of gel contraction through the relaxinreceptor RXFP-1. I have evidence to suggest that the inhibition of contractionmay in part be via nitric oxide release in HSC. In conclusion I propose thatRXFP-1 is a potential therapeutic target in end stage human liver disease,targeting fibrosis and portal blood hypertension via both resolution of thephenotypic collagen deposition and vascular constriction associated with thehuman hepatic stellate cell

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    No full text
    The original version of this article unfortunately contained a mistake. The members of the ESICM Trials Group Collaborators were not shown in the article but only in the ESM. The full list of collaborators is shown below. The original article has been corrected

    1994 Annual Selected Bibliography: Asian American Studies and the Crisis of Practice

    No full text
    corecore